Company intelligence / Profile preview

Semzyme

Santa Barbara, California, United States
Ownership
Private
Development stage
Other
01

Overview

Semzyme Inc. was a pioneering nanobiotechnology company founded in 2001 by Dr. Angela Belcher and Dr. Evelyn Hu to commercialize a revolutionary biomimetic approach to material synthesis. The company utilized genetically engineered viruses, specifically the M13 bacteriophage, as biological templates to direct the assembly of inorganic materials such as semiconductors, metallic nanowires, and magnetic particles. This "bottom-up" fabrication method allowed for the creation of nanoscale electronic components under environmentally friendly conditions, bypassing the extreme temperatures and harsh chemicals of traditional semiconductor manufacturing. In 2004, Semzyme was renamed Cambrios Technologies, which went on to become a leader in silver nanowire-based transparent conductors for touchscreens and flexible displays.

Therapeutic areas
Other
Modalities
PeptidesVirusesNanoparticle
Industry
Non-Drug Biotech
02

Partnerships

Samsung VenturesDow Corning

Beyond the preview

Go deeper on Semzyme.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Semzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call